May Marsh

May Marsh

Auto-generated profile, based on publicly available information

May Marsh

Department of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, UK

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
APAndrea E. Prota
Andrea E. Prota
KBKatja Bargsten
Katja Bargsten
JJosé Fernando Díaz
José Fernando Díaz
MMMay Marsh
May Marsh
CCCarmen Cuevas
Carmen Cuevas
MSMichel Steinmetz
Michel Steinmetz
Significance: Microtubules are dynamic protein filaments assembled from tubulin subunits, which play a key role for cell division. Ligands that target microtubules and affect their dynamics belong to the most successful classes of chemotherapeutic drugs against cancer by inhibiting cell proliferation. Here we have analyzed three structurally unrelated drugs that destabilize microtubules, using X-ray crystallography. The data reveal a new tubulin-binding site for these drugs, which renders their mechanism of action distinct from that of other types of microtubule assembly inhibitors. Similar key interactions with tubulin are observed for all three ligands, thus defining a common pharmacophore. Our results offer an opportunity for the rational design of potent tubulin modulators for the development of more efficient cancer therapies.

14 September 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
TWTobias Weinert
Tobias Weinert
NONatacha Olieric
Natacha Olieric
RCRobert Cheng
Robert Cheng
SBSteffen Brünle
Steffen Brünle
DJDaniel James
Daniel James
JSJörg Standfuss
Jörg Standfuss
Historically, room-temperature structure determination was succeeded by cryo-crystallography to mitigate radiation damage. Here, we demonstrate that serial millisecond crystallography at a synchrotron beamline equipped with high-viscosity injector and high frame-rate detector allows typical crystallographic experiments to be performed at room-temperature. Using a crystal scanning approach, we determine the high-resolution structure of the radiation sensitive molybdenum storage protein, demonstrate soaking of the drug colchicine into tubulin and native sulfur phasing of the human G protein-coupled adenosine receptor. Serial crystallographic data for molecular replacement already converges in 1,000–10,000 diffraction patterns, which we collected in 3 to maximally 82 minutes. Compared with serial data we collected at a free-electron laser, the synchrotron data are of slightly lower resolution, however fewer diffraction patterns are needed for de novo phasing. Overall, the data we collected by room-temperature serial crystallography are of comparable quality to cryo-crystallographic data and can be routinely collected at synchrotrons.

27 January 2014 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
APAndrea E. Prota
Andrea E. Prota
KBKatja Bargsten
Katja Bargsten
PNPeter T. Northcote
Peter T. Northcote
MMMay Marsh
May Marsh
KAKarl‐Heinz Altmann
Karl‐Heinz Altmann
MSMichel Steinmetz
Michel Steinmetz

16 March 2007 in Acta Crystallographica Section D Structural Biology
Verified
Journal Article
Closed access
PDF file
ADAllan D'ARcy
Allan D'ARcy
FVFrederic Villard
Frederic Villard
MMMay Marsh
May Marsh

29 August 2014 in Acta Crystallographica Section F Structural Biology Communications
Verified
Journal Article
Open access
PDF file
ADAllan D'ARcy
Allan D'ARcy
TBTerese Bergfors
Terese Bergfors
SCSandra W. Cowan-Jacob
Sandra W. Cowan-Jacob
MMMay Marsh
May Marsh
Protein crystals obtained in initial screens typically require optimization before they are of X-ray diffraction quality. Seeding is one such optimization method. In classical seeding experiments, the seed crystals are put into new, albeit similar, conditions. The past decade has seen the emergence of an alternative seeding strategy: microseed matrix screening (MMS). In this strategy, the seed crystals are transferred into conditions unrelated to the seed source. Examples of MMS applications from in-house projects and the literature include the generation of multiple crystal forms and different space groups, better diffracting crystals and crystallization of previously uncrystallizable targets. MMS can be implemented robotically, making it a viable option for drug-discovery programs. In conclusion, MMS is a simple, time- and cost-efficient optimization method that is applicable to many recalcitrant crystallization problems.

23 January 2013 in ChemBioChem
Verified
Journal Article
Open access
PDF file
DSDuncan E. Scott
Duncan E. Scott
MEMatthias T. Ehebauer
Matthias T. Ehebauer
TPTara Louise Pukala
Tara Louise Pukala
MMMay Marsh
May Marsh
TBTom L. Blundell
Tom L. Blundell
MHMarko Hyvönen
Marko Hyvönen
The ability to identify inhibitors of protein–protein interactions represents a major challenge in modern drug discovery and in the development of tools for chemical biology. In recent years, fragment‐based approaches have emerged as a new methodology in drug discovery; however, few examples of small molecules that are active against chemotherapeutic targets have been published. Herein, we describe the fragment‐based approach of targeting the interaction between the tumour suppressor BRCA2 and the recombination enzyme RAD51; it makes use of a screening pipeline of biophysical techniques that we expect to be more generally applicable to similar targets. Disruption of this interaction in vivo is hypothesised to give rise to cellular hypersensitivity to radiation and genotoxic drugs. We have used protein engineering to create a monomeric form of RAD51 by humanising a thermostable archaeal orthologue, RadA, and used this protein for fragment screening. The initial fragment hits were thoroughly validated biophysically by isothermal titration calorimetry (ITC) and NMR techniques and observed by X‐ray crystallography to bind in a shallow surface pocket that is occupied in the native complex by the side chain of a phenylalanine from the conserved FxxA interaction motif found in BRCA2. This represents the first report of fragments or any small molecule binding at this protein–protein interaction site.